Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1944th out of 2,041 stocks

Surgical Appliances & Supplies Industry

39th out of 40 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Pathfinder Cell Therapy.

0.0 Community Rank

Outperform Votes
Pathfinder Cell Therapy has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Pathfinder Cell Therapy has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Pathfinder Cell Therapy and other stocks. Vote “Outperform” if you believe PFND will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PFND will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Pathfinder Cell Therapy does not currently pay a dividend.
Dividend Growth
Pathfinder Cell Therapy does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pathfinder Cell Therapy insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 15.10% of the stock of Pathfinder Cell Therapy is held by insiders.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Pathfinder Cell Therapy (OTCMKTS:PFND) Frequently Asked Questions

What stocks does MarketBeat like better than Pathfinder Cell Therapy?

Wall Street analysts have given Pathfinder Cell Therapy a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pathfinder Cell Therapy wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Pathfinder Cell Therapy's key executives?

Pathfinder Cell Therapy's management team includes the following people:

Mr. Joerg Gruber, Founder & Chairman (Age 60, Pay $20k)
Dr. Richard L. Franklin, Founder, CEO, Pres, Sec. & Exec. Director (Age 76, Pay $120k)
Mr. John M. Benson, CFO & Treasurer (Age 59, Pay $119k)

Who are some of Pathfinder Cell Therapy's key competitors?

Some companies that are related to Pathfinder Cell Therapy include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), Coloplast A/S (CLPBY), Smith & Nephew (SNN), STERIS (STE), Demant A/S (WILYY), Shandong Weigao Group Medical Polymer (SHWGF), Wound Management Technologies (WNDM), MSA Safety (MSA), Avanos Medical (AVNS), Establishment Labs (ESTA), Eargo (EAR) and Inogen (INGN).
View all of PFND's competitors.

What is Pathfinder Cell Therapy's stock symbol?

Pathfinder Cell Therapy trades on the OTCMKTS under the ticker symbol "PFND."

How do I buy shares of Pathfinder Cell Therapy?

Shares of PFND can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pathfinder Cell Therapy's stock price today?

One share of PFND stock can currently be purchased for approximately $0.01.

How many employees does Pathfinder Cell Therapy have?

Pathfinder Cell Therapy employs 1 workers across the globe.

What is Pathfinder Cell Therapy's official website?

The official website for Pathfinder Cell Therapy is www.pathfindercelltherapy.com.

Where are Pathfinder Cell Therapy's headquarters?

Pathfinder Cell Therapy is headquartered at 12 Bow Street, Cambridge MA, 02138.

How can I contact Pathfinder Cell Therapy?

Pathfinder Cell Therapy's mailing address is 12 Bow Street, Cambridge MA, 02138. The company can be reached via phone at 617-245-0289.

This page was last updated on 5/7/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Pathfinder Cell Therapy Stock Forecast, Price & News

Adding

Adding

Adding Pathfinder Cell Therapy, Inc.

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Headlines

About Pathfinder Cell Therapy

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

Percentage Held by Insiders